PharmExec Blog
Follow Us
RSS
Bookstore
Category Archives: Biotech
Medical Economics: New Highs for a Historic Brand
Medical Economics has been named "Media Brand of the Year" but MM&M magazie, one of sister publication Pharm Exec's main competitors.
Also posted in Advertising, E-Media, Marketing, Medical Education, Strategy, healthcare Tagged Advanstar, life sciences, Medical Economics, MM&M, primary care physicians Leave a comment
Roche Ups the Stakes on Personalized Medicine
By Patricia Van Arnum, Pharmaceutical Technology.
Personalized medicine, which targets individualized treatment and care based on personal and genetic variations, holds much promise for the pharmaceutical industry. Several pharmaceutical majors continue to invest in this emerging field as evident by Roche’s $5.7-billion bid last week for Illumina, a provider of gene-sequencing tools and related analytics.
Also posted in Europe, Global, Guest Blog Tagged diagnostics, Personalized medicine, Roche 1 Comment
Putting the M Back in M&A
Joe Panetta, president and CEO of BIOCOM, discusses an emerging model of M&As in which human and IP assets are valued and biotech brings expertise to Big Pharma as venture capitalist funding dwindles and patent cliffs loom large.
Pharm Exec: Can you tell me about how small biotech and specialty companies have started switching from relying [...]
Also posted in Agency Insight, Deals, FDA Tagged BIOCOM, Joe Panetta, M&A, venture capital Leave a comment
The HCR Taxman Cometh
By Tom Norton
As the country struggles with the current economic malaise, and the pharmaceutical industry enters into yet another difficult quarter of “trying to make the numbers,” one matter that I doubt many Rx execs are thinking about today is the HCR Taxman. That’s too bad. They probably should. That’s because he’s coming for the [...]
Also posted in Advertising, Agency Insight, Corporate Responsibility, Strategy, compliance Comments closed
Shrinking Economy Hits California Biosector